‘Dream Team’ stands up to melanoma cancer

 December 14, 2011:

Joe Caspermeyer, Biodesign Institute via http://asunews.asu.edu/20111214_melanomadreamteam

ASU’s Deirdre Meldrum and Joshua LaBaer, of the Biodesign Institute, have been named to the new Melanoma Dream Team created by Stand Up to Cancer, the Melanoma Research Alliance and the American Association for Cancer Research (AACR). The collaborative Dream Team project, involving scientists from top research institutions across the country, is focused on developing targeted, personalized therapies for a subtype of skin cancer that is difficult to treat. The Translational Genomics Research Institute (TGen) and the Barbara Ann Karmanos Cancer Institute will lead the $6 million national and international study.Continue reading

SBIR and STTR Reauthorized for Six Years

Today the SBIR was reauthorized for a period of 6 years, ending September 30, 2017.  This  includes STTR, and what was the Commercialization Pilot Program (CPP), now to be known as the Commercialization Readiness Program (CRP).  The reauthorization was included in the National Defense Authorization Act of 2012 (NDAA) HR.1540.

The bill has been sent to the President to sign the bill into law, and he has said he would.Continue reading

One step closer on the road to SBIR Reauthorization

The SBIR/STTR program has not been reauthorized yet but we are one step closer as the December 16th deadline approaches.

Monday (December 12, 2012) word of a Senate/House compromise was announced that may lead to a positive outcome that would reauthorize the SBIR/STTR program for six years.  This would be a huge improvement over the multiple short term extensions we have seen  in recent years. Continue reading